CAVOXIN
UNII A4QC4S74NA

Substance Identification & Data

This profile provides standardized clinical and technical data for Cavoxin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) A4QC4S74NA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 101241-17-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
A4QC4S74NA
CAS Registry Number
101241-17-2
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CAVOXIN
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C17H20O6
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
NLNHSFBYVSNFRF-BSWSSELBSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
C(c1c(c(c(cc1CO)OC)C(/C=C/C=C/CCC)=O)O)(=O)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cavoxin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

CAVOXIN

Systematic Nomenclature

2-HYDROXY-6-(HYDROXYMETHYL)-4-METHOXY-3-((2E,4E)-1-OXO-2,4-OCTADIEN-1-YL)BENZOIC ACID
BENZOIC ACID, 2-HYDROXY-6-(HYDROXYMETHYL)-4-METHOXY-3-((2E,4E)-1-OXO-2,4-OCTADIEN-1-YL)-